65 related articles for article (PubMed ID: 12914757)
1. Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?
Madjd Z; Durrant LG; Pinder SE; Ellis IO; Ronan J; Lewis S; Rushmere NK; Spendlove I
Cancer Immunol Immunother; 2005 Feb; 54(2):149-56. PubMed ID: 15378282
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
Bjørge L; Jensen TS; Matre R
Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
[TBL] [Abstract][Full Text] [Related]
3. Complement decay accelerating factor (DAF)/CD55 in cancer.
Spendlove I; Ramage JM; Bradley R; Harris C; Durrant LG
Cancer Immunol Immunother; 2006 Aug; 55(8):987-95. PubMed ID: 16485129
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
Hellrung DJ; Kisselev S; Link CJ
Cancer Immunol Immunother; 2007 Jan; 56(1):25-34. PubMed ID: 16612594
[TBL] [Abstract][Full Text] [Related]
5. Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis.
Van Den Berg CW; De Andrade RM; Magnoli FC; Marchbank KJ; Tambourgi DV
Immunology; 2002 Sep; 107(1):102-10. PubMed ID: 12225368
[TBL] [Abstract][Full Text] [Related]
6. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
Watson NF; Durrant LG; Madjd Z; Ellis IO; Scholefield JH; Spendlove I
Cancer Immunol Immunother; 2006 Aug; 55(8):973-80. PubMed ID: 16151805
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Okroj M; Corrales L; Stokowska A; Pio R; Blom AM
Cancer Immunol Immunother; 2009 Nov; 58(11):1771-80. PubMed ID: 19259664
[TBL] [Abstract][Full Text] [Related]
8. Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen.
Wang Y; Liao J; Yang YJ; Wang Z; Qin F; Zhu SM; Zheng H; Wang YP
Oncol Lett; 2018 Jun; 15(6):9061-9068. PubMed ID: 29805637
[TBL] [Abstract][Full Text] [Related]
9. A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.
Bos JW; Groen EJN; Otten HG; Budding K; van Eijk RPA; Curial C; Kardol-Hoefnagel T; Goedee HS; van den Berg LH; van der Pol WL
J Peripher Nerv Syst; 2024 Mar; ():. PubMed ID: 38528725
[TBL] [Abstract][Full Text] [Related]
10. Amino acid transporter expression in the endometrium and conceptus membranes during early equine pregnancy.
Gibson C; de Ruijter-Villani M; Rietveld J; Stout TAE
Reprod Fertil Dev; 2018 Nov; 30(12):1675-1688. PubMed ID: 29903343
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells: Emergent Nature of Tumor Emergency.
Efremov YR; Proskurina AS; Potter EA; Dolgova EV; Efremova OV; Taranov OS; Ostanin AA; Chernykh ER; Kolchanov NA; Bogachev SS
Front Genet; 2018; 9():544. PubMed ID: 30505319
[TBL] [Abstract][Full Text] [Related]
12. A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.
Heckmann JM; Uwimpuhwe H; Ballo R; Kaur M; Bajic VB; Prince S
Genes Immun; 2010 Jan; 11(1):1-10. PubMed ID: 19675582
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.
Cauvi DM; Cauvi G; Pollard KM
J Immunol; 2006 Sep; 177(6):3837-47. PubMed ID: 16951346
[TBL] [Abstract][Full Text] [Related]
14. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
16. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
17. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
Varsano S; Frolkis I; Shapiro H; Ophir D
Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
[TBL] [Abstract][Full Text] [Related]
18. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
19. [The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis].
Wojnicz D; Bar J; Jankowski S
Postepy Hig Med Dosw; 2002; 56(5):603-16. PubMed ID: 12587428
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
